Abstract

BackgroundAntiphospholipid antibodies (aPL) are risk factors for Adverse Pregnancy Outcome (APO). The therapeutic strategy to adopt in aPL patients during pregnancy should in fact consider different clinical and serological risk...

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call